TreeWAS – Variant ID: rs17711722

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T42.4 Benzodiazepines	0.081	0.919	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.079	0.921	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.078	0.922	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.077	0.923	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.077	0.923	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.074	0.926	0.000
T42.0 Hydantoin derivatives	0.070	0.930	0.000
T43.2 Other and unspecified antidepressants	0.068	0.932	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.068	0.932	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.067	0.933	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.067	0.933	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.061	0.939	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.061	0.939	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.060	0.940	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.059	0.941	0.000
T45.5 Anticoagulants	0.058	0.942	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.057	0.943	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.057	0.943	0.000
T42.3 Barbiturates	0.057	0.943	0.000
T42.2 Succinimides and oxazolidinediones	0.057	0.943	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.056	0.943	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.055	0.945	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.055	0.945	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.055	0.945	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.055	0.945	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.055	0.945	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.055	0.945	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.055	0.945	0.000
T44.0 Anticholinesterase agents	0.055	0.945	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.054	0.946	0.000
T45.2 Vitamins, not elsewhere classified	0.054	0.946	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.054	0.946	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.053	0.947	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.053	0.947	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.052	0.948	0.000
T43.9 Psychotropic drug, unspecified	0.052	0.948	0.000
I34.0 Mitral (valve) insufficiency	0.052	0.948	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.052	0.948	0.000
T42.1 Iminostilbenes	0.052	0.948	0.000
C79.6 Secondary malignant neoplasm of ovary	0.051	0.949	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.051	0.949	0.000
T50.1 Loop [high-ceiling] diuretics	0.051	0.949	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.051	0.949	0.000
C79 Secondary malignant neoplasm of other sites	0.050	0.950	0.000
T36 Poisoning by systemic antibiotics	0.050	0.950	0.000
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.050	0.950	0.000
T45.0 Antiallergic and antiemetic drugs	0.050	0.950	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.048	0.952	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.048	0.952	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.048	0.952	0.000
T45.8 Other primarily systemic and haematological agents	0.048	0.952	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.048	0.952	0.000
T45.6 Fibrinolysis-affecting drugs	0.048	0.952	0.000
T45.4 Iron and its compounds	0.048	0.952	0.000
T45.3 Enzymes, not elsewhere classified	0.048	0.952	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.048	0.952	0.000
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system	0.048	0.952	0.000
T43.6 Psychostimulants with abuse potential	0.046	0.954	0.000
T50.4 Drugs affecting uric acid metabolism	0.046	0.954	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.045	0.955	0.000
T47.6 Antidiarrhoeal drugs	0.045	0.955	0.000
T50.7 Analeptics and opioid receptor antagonists	0.044	0.956	0.000
T50.5 Appetite depressants	0.044	0.956	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.044	0.956	0.000
T50.0 Mineralocorticoids and their antagonists	0.044	0.956	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.044	0.956	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.044	0.956	0.000
T47.7 Emetics	0.044	0.956	0.000
T47.5 Digestants	0.044	0.956	0.000
T47.3 Saline and osmotic laxatives	0.044	0.956	0.000
T40.2 Other opioids	0.044	0.956	0.000
C79.5 Secondary malignant neoplasm of bone and bone marrow	0.044	0.956	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.043	0.957	0.000
T37.5 Antiviral drugs	0.043	0.957	0.000
T37.4 Anthelminthics	0.043	0.957	0.000
T37.3 Other antiprotozoal drugs	0.043	0.957	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.043	0.957	0.000
T37.1 Antimycobacterial drugs	0.043	0.957	0.000
T37.0 Sulphonamides	0.043	0.957	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.042	0.958	0.000
C79.9 Secondary malignant neoplasm, unspecified site	0.042	0.958	0.000
T47.0 Histamine H(2)-receptor antagonists	0.042	0.958	0.000
T47.2 Stimulant laxatives	0.041	0.959	0.000
C79.7 Secondary malignant neoplasm of adrenal gland	0.041	0.959	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.040	0.960	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.040	0.960	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.040	0.960	0.000
T41.5 Therapeutic gases	0.040	0.960	0.000
T41.4 Anaesthetic, unspecified	0.040	0.960	0.000
T41.3 Local anaesthetics	0.040	0.960	0.000
T41.2 Other and unspecified general anaesthetics	0.040	0.960	0.000
T41.1 Intravenous anaesthetics	0.040	0.960	0.000
T41.0 Inhaled anaesthetics	0.040	0.960	0.000
T36.3 Macrolides	0.039	0.960	0.000
T47.4 Other laxatives	0.039	0.960	0.000
T40.4 Other synthetic narcotics	0.040	0.960	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.039	0.961	0.000
T40.8 Lysergide [LSD]	0.039	0.961	0.000
T40.7 Cannabis (derivatives)	0.039	0.961	0.000
T40.3 Methadone	0.039	0.961	0.000
T40.1 Heroin	0.039	0.961	0.000
T40.0 Opium	0.039	0.961	0.000
T40.5 Cocaine	0.039	0.961	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.039	0.961	0.000
T50.8 Diagnostic agents	0.038	0.961	0.000
T49.9 Topical agent, unspecified	0.038	0.962	0.000
T49.8 Other topical agents	0.038	0.962	0.000
T49.7 Dental drugs, topically applied	0.038	0.962	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.038	0.962	0.000
T49.5 Ophthalmological drugs and preparations	0.038	0.962	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.038	0.962	0.000
T49.3 Emollients, demulcents and protectants	0.038	0.962	0.000
T49.2 Local astringents and local detergents	0.038	0.962	0.000
T49.1 Antipruritics	0.038	0.962	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.038	0.962	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.037	0.963	0.000
T48.5 Anti-common-cold drugs	0.037	0.963	0.000
T48.4 Expectorants	0.037	0.963	0.000
T48.3 Antitussives	0.037	0.963	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.037	0.963	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.037	0.963	0.000
T48.0 Oxytocic drugs	0.037	0.963	0.000
T36.4 Tetracyclines	0.037	0.963	0.000
T36.8 Other systemic antibiotics	0.037	0.963	0.000
T36.9 Systemic antibiotic, unspecified	0.036	0.964	0.000
T36.7 Antifungal antibiotics, systemically used	0.036	0.964	0.000
T36.6 Rifamycins	0.036	0.964	0.000
T36.5 Aminoglycosides	0.036	0.964	0.000
T36.2 Chloramphenicol group	0.036	0.964	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.036	0.964	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.036	0.964	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.035	0.965	0.000
T46.7 Peripheral vasodilators	0.035	0.965	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.035	0.965	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.034	0.966	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.034	0.966	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.034	0.966	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.034	0.966	0.000
T46.1 Calcium-channel blockers	0.033	0.967	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.033	0.967	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.032	0.967	0.000
C79.2 Secondary malignant neoplasm of skin	0.032	0.968	0.000
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs	0.032	0.968	0.000
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.032	0.968	0.000
T40.6 Other and unspecified narcotics	0.031	0.969	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.031	0.969	0.000
T38.9 Other and unspecified hormone antagonists	0.030	0.969	0.000
T38.7 Androgens and anabolic congeners	0.030	0.969	0.000
T38.5 Other oestrogens and progestogens	0.030	0.969	0.000
T38.4 Oral contraceptives	0.030	0.969	0.000
T38.2 Antithyroid drugs	0.030	0.969	0.000
T38.0 Glucocorticoids and synthetic analogues	0.030	0.969	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.029	0.971	0.000
T38.1 Thyroid hormones and substitutes	0.028	0.971	0.000
T36.0 Penicillins	0.022	0.978	0.001
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.020	0.979	0.000
I34 Nonrheumatic mitral valve disorders	0.018	0.982	0.000
C79.8 Secondary malignant neoplasm of other specified sites	0.017	0.983	0.000
Z86.5 Personal history of other mental and behavioural disorders	0.016	0.984	0.000
I12.9 Hypertensive renal disease without renal failure	0.016	0.984	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.016	0.984	0.000
I27.0 Primary pulmonary hypertension	0.015	0.985	0.000
I34.8 Other nonrheumatic mitral valve disorders	0.014	0.986	0.000
I34.9 Nonrheumatic mitral valve disorder, unspecified	0.013	0.986	0.000
E87.7 Fluid overload	0.013	0.987	0.000
R22.2 Localised swelling, mass and lump, trunk	0.000	0.988	0.012
I34.2 Nonrheumatic mitral (valve) stenosis	0.012	0.988	0.000
I05.2 Mitral stenosis with insufficiency	0.012	0.988	0.000
I05.0 Mitral stenosis	0.012	0.988	0.000
Z85.4 Personal history of malignant neoplasm of genital organs	0.012	0.988	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.011	0.989	0.000
T39.4 Antirheumatics, not elsewhere classified	0.011	0.989	0.000
T39.2 Pyrazolone derivatives	0.011	0.989	0.000
T39.0 Salicylates	0.011	0.989	0.000
I05 Rheumatic mitral valve diseases	0.011	0.989	0.000
Q61.5 Medullary cystic kidney	0.010	0.990	0.000
Z92.1 Personal history of long-term (current) use of anticoagulants	0.010	0.990	0.000
Q61 Cystic kidney disease	0.010	0.990	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.009	0.991	0.000
Q61.3 Polycystic kidney, unspecified	0.009	0.991	0.000
Q61.9 Cystic kidney disease, unspecified	0.009	0.991	0.000
Z86.3 Personal history of endocrine, nutritional and metabolic diseases	0.009	0.991	0.000
I27 Other pulmonary heart diseases	0.009	0.991	0.000
I27.8 Other specified pulmonary heart diseases	0.009	0.991	0.000
I05.1 Rheumatic mitral insufficiency	0.008	0.992	0.000
I05.8 Other mitral valve diseases	0.008	0.992	0.000
I34.1 Mitral (valve) prolapse	0.008	0.992	0.000
I05.9 Mitral valve disease, unspecified	0.008	0.992	0.000
J33.9 Nasal polyp, unspecified	0.000	0.993	0.007
Q61.8 Other cystic kidney diseases	0.007	0.993	0.000
Q61.1 Polycystic kidney, infantile type	0.007	0.993	0.000
Z52.4 Kidney donor	0.007	0.993	0.000
Q61.2 Polycystic kidney, adult type	0.007	0.993	0.000
Q61.4 Renal dysplasia	0.007	0.993	0.000
D03.3 Melanoma in situ of other and unspecified parts of face	0.007	0.993	0.000
Q60-Q64 Congenital malformations of the urinary system	0.007	0.993	0.000
D07.5 Prostate	0.007	0.993	0.000
D03 Melanoma in situ	0.007	0.993	0.000
I27.1 Kyphoscoliotic heart disease	0.006	0.994	0.000
D03.4 Melanoma in situ of scalp and neck	0.006	0.994	0.000
D03.5 Melanoma in situ of trunk	0.006	0.994	0.000
Q62 Congenital obstructive defects of renal pelvis and congenital malformations of ureter	0.006	0.994	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.005	0.994	0.001
Z43.3 Attention to colostomy	0.006	0.994	0.000
Q63 Other congenital malformations of kidney	0.005	0.994	0.000
Q64 Other congenital malformations of urinary system	0.005	0.994	0.000
D03.6 Melanoma in situ of upper limb, including shoulder	0.005	0.995	0.000
D03.2 Melanoma in situ of ear and external auricular canal	0.005	0.995	0.000
Q60 Renal agenesis and other reduction defects of kidney	0.005	0.995	0.000
Q61.0 Congenital single renal cyst	0.005	0.995	0.000
Q62.3 Other obstructive defects of renal pelvis and ureter	0.005	0.995	0.000
F30.9 Manic episode, unspecified	0.005	0.995	0.000
D03.9 Melanoma in situ, unspecified	0.005	0.995	0.000
D03.8 Melanoma in situ of other sites	0.005	0.995	0.000
Q62.5 Duplication of ureter	0.005	0.995	0.000
M71.38 Other bursal cyst (Other)	0.005	0.995	0.000
D07 Carcinoma in situ of other and unspecified genital organs	0.005	0.995	0.000
Q64.7 Other congenital malformations of bladder and urethra	0.005	0.995	0.000
D03.1 Melanoma in situ of eyelid, including canthus	0.005	0.995	0.000
R47.1 Dysarthria and anarthria	0.000	0.995	0.005
C91.0 Acute lymphoblastic leukaemia	0.005	0.995	0.000
I27.2 Other secondary pulmonary hypertension	0.005	0.995	0.000
Q63.1 Lobulated, fused and horseshoe kidney	0.005	0.995	0.000
D03.0 Melanoma in situ of lip	0.005	0.995	0.000
Q63.8 Other specified congenital malformations of kidney	0.005	0.995	0.000
Z50.8 Care involving use of rehabilitation procedures	0.005	0.995	0.000
W13.9 Unspecified place	0.005	0.995	0.000
Q64.4 Malformation of urachus	0.005	0.995	0.000
Z37.0 Single live birth	0.000	0.995	0.005
D03.7 Melanoma in situ of lower limb, including hip	0.005	0.995	0.000
Q62.8 Other congenital malformations of ureter	0.004	0.995	0.000
Q62.7 Congenital vesico-uretero-renal reflux	0.004	0.995	0.000
Q62.6 Malposition of ureter	0.004	0.995	0.000
Q62.4 Agenesis of ureter	0.004	0.995	0.000
Q62.2 Congenital megaloureter	0.004	0.995	0.000
Q62.1 Atresia and stenosis of ureter	0.004	0.995	0.000
Q62.0 Congenital hydronephrosis	0.004	0.995	0.000
D07.1 Vulva	0.005	0.995	0.000
B02.9 Zoster without complication	0.000	0.996	0.004
I47.2 Ventricular tachycardia	0.004	0.996	0.000
Q63.9 Congenital malformation of kidney, unspecified	0.004	0.996	0.000
Q63.3 Hyperplastic and giant kidney	0.004	0.996	0.000
Q60.0 Renal agenesis, unilateral	0.004	0.996	0.000
Q64.9 Congenital malformation of urinary system, unspecified	0.004	0.996	0.000
Q64.8 Other specified congenital malformations of urinary system	0.004	0.996	0.000
Q64.6 Congenital diverticulum of bladder	0.004	0.996	0.000
Q64.5 Congenital absence of bladder and urethra	0.004	0.996	0.000
Q64.2 Congenital posterior urethral valves	0.004	0.996	0.000
Q64.1 Exstrophy of urinary bladder	0.004	0.996	0.000
Q64.0 Epispadias	0.004	0.996	0.000
M71.3 Other bursal cyst	0.004	0.996	0.000
I27.9 Pulmonary heart disease, unspecified	0.004	0.996	0.000
M71.34 Other bursal cyst (Hand)	0.004	0.996	0.000
D21.0 Connective and other soft tissue of head, face and neck	0.004	0.996	0.000
R82.9 Other and unspecified abnormal finding in urine	0.000	0.996	0.004
C62.9 Testis, unspecified	0.000	0.996	0.004
Y60.4 During endoscopic examination	0.004	0.996	0.000
Q60.6 Potter's syndrome	0.004	0.996	0.000
Q60.5 Renal hypoplasia, unspecified	0.004	0.996	0.000
Q60.4 Renal hypoplasia, bilateral	0.004	0.996	0.000
Q60.3 Renal hypoplasia, unilateral	0.004	0.996	0.000
Q60.1 Renal agenesis, bilateral	0.004	0.996	0.000
Z03.3 Observation for suspected nervous system disorder	0.000	0.996	0.004
Q63.0 Accessory kidney	0.004	0.996	0.000
U80.1 Methicillin resistant agent	0.004	0.996	0.000
I12 Hypertensive renal disease	0.004	0.996	0.000
C02.9 Tongue, unspecified	0.004	0.996	0.000
X63.0 Home	0.004	0.996	0.000
Z52 Donors of organs and tissues	0.004	0.996	0.000
D07.6 Other and unspecified male genital organs	0.004	0.996	0.000
D07.3 Other and unspecified female genital organs	0.004	0.996	0.000
D07.0 Endometrium	0.004	0.996	0.000
D07.4 Penis	0.004	0.996	0.000
D21.1 Connective and other soft tissue of upper limb, including shoulder	0.004	0.996	0.000
C91 Lymphoid leukaemia	0.004	0.996	0.000
R47 Speech disturbances, not elsewhere classified	0.000	0.996	0.004
F40.2 Specific (isolated) phobias	0.000	0.996	0.004
M71.37 Other bursal cyst (Ankle and foot)	0.004	0.996	0.000
D07.2 Vagina	0.003	0.996	0.000
Q60.2 Renal agenesis, unspecified	0.003	0.996	0.000
D21 Other benign neoplasms of connective and other soft tissue	0.004	0.996	0.000
D21.2 Connective and other soft tissue of lower limb, including hip	0.004	0.996	0.000
R47.0 Dysphasia and aphasia	0.000	0.997	0.003
I05-I09 Chronic rheumatic heart diseases	0.003	0.997	0.000
Z43.4 Attention to other artificial openings of digestive tract	0.003	0.997	0.000
Z52.8 Donor of other organs and tissues	0.003	0.997	0.000
C91.4 Hairy-cell leukaemia	0.003	0.997	0.000
Y83.3 Surgical operation with formation of external stoma	0.003	0.997	0.000
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.003	0.997	0.000
C91.5 Adult T-cell leukaemia	0.003	0.997	0.000
F30 Manic episode	0.003	0.997	0.000
Q63.2 Ectopic kidney	0.003	0.997	0.000
M47.87 Other spondylosis (Lumbosacral region)	0.000	0.997	0.003
M71.39 Other bursal cyst (Site unspecified)	0.003	0.997	0.000
M71.36 Other bursal cyst (Lower leg)	0.003	0.997	0.000
M71.35 Other bursal cyst (Pelvic region and thigh)	0.003	0.997	0.000
M71.33 Other bursal cyst (Forearm)	0.003	0.997	0.000
M71.32 Other bursal cyst (Upper arm)	0.003	0.997	0.000
M71.31 Other bursal cyst (Shoulder region)	0.003	0.997	0.000
M71.30 Other bursal cyst (Multiple sites)	0.003	0.997	0.000
Z43.8 Attention to other artificial openings	0.003	0.997	0.000
O24.4 Diabetes mellitus arising in pregnancy	0.003	0.997	0.000
Z43 Attention to artificial openings	0.003	0.997	0.000
R47.8 Other and unspecified speech disturbances	0.000	0.997	0.003
C78.0 Secondary malignant neoplasm of lung	0.003	0.997	0.000
F30.2 Mania with psychotic symptoms	0.003	0.997	0.000
C91.9 Lymphoid leukaemia, unspecified	0.003	0.997	0.000
Z52.0 Blood donor	0.003	0.997	0.000
J81 Pulmonary oedema	0.003	0.997	0.000
Z52.9 Donor of unspecified organ or tissue	0.003	0.997	0.000
Z52.7 Heart donor	0.003	0.997	0.000
Z52.6 Liver donor	0.003	0.997	0.000
Z52.5 Cornea donor	0.003	0.997	0.000
Z52.1 Skin donor	0.003	0.997	0.000
X63 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system	0.003	0.997	0.000
D21.3 Connective and other soft tissue of thorax	0.003	0.997	0.000
Z52.2 Bone donor	0.003	0.997	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.003	0.997	0.000
C91.7 Other lymphoid leukaemia	0.003	0.997	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.003	0.997	0.000
C91.3 Prolymphocytic leukaemia	0.003	0.997	0.000
C91.2 Subacute lymphocytic leukaemia	0.003	0.997	0.000
E87.2 Acidosis	0.003	0.997	0.000
Q64.3 Other atresia and stenosis of urethra and bladder neck	0.002	0.997	0.001
D21.5 Connective and other soft tissue of pelvis	0.003	0.997	0.000
C62 Malignant neoplasm of testis	0.000	0.997	0.003
D21.6 Connective and other soft tissue of trunk, unspecified	0.003	0.997	0.000
Z52.3 Bone marrow donor	0.003	0.997	0.000
F30.0 Hypomania	0.003	0.997	0.000
I26-I28 Pulmonary heart disease and diseases of pulmonary circulation	0.003	0.997	0.000
D36.7 Other specified sites	0.003	0.997	0.000
R27.8 Other and unspecified lack of coordination	0.003	0.997	0.000
N48.0 Leukoplakia of penis	0.003	0.997	0.000
Z43.6 Attention to other artificial openings of urinary tract	0.003	0.997	0.000
R82.4 Acetonuria	0.000	0.997	0.003
M50.1 Cervical disk disorder with radiculopathy	0.003	0.997	0.000
Z43.0 Attention to tracheostomy	0.003	0.997	0.000
C61 Malignant neoplasm of prostate	0.003	0.997	0.000
C62.1 Descended testis	0.000	0.997	0.003
D21.4 Connective and other soft tissue of abdomen	0.003	0.997	0.000
I11.9 Hypertensive heart disease without (congestive) heart failure	0.003	0.997	0.000
C76 Malignant neoplasm of other and ill-defined sites	0.003	0.997	0.000
D00-D09 In situ neoplasms	0.003	0.997	0.000
F30.8 Other manic episodes	0.003	0.997	0.000
I06 Rheumatic aortic valve diseases	0.003	0.997	0.000
F06.7 Mild cognitive disorder	0.003	0.997	0.000
F30.1 Mania without psychotic symptoms	0.003	0.997	0.000
R82 Other abnormal findings in urine	0.000	0.997	0.003
V23.4 Driver injured in traffic accident	0.003	0.997	0.000
I07 Rheumatic tricuspid valve diseases	0.003	0.997	0.000
D75.1 Secondary polycythaemia	0.000	0.997	0.003
Z43.9 Attention to unspecified artificial opening	0.002	0.997	0.000
Z43.7 Attention to artificial vagina	0.002	0.997	0.000
X41.9 Unspecified place	0.003	0.997	0.000
M21.57 Acquired clawhand, clubhand, clawfoot and clubfoot (Ankle and foot)	0.003	0.997	0.000
D21.9 Connective and other soft tissue, unspecified	0.002	0.997	0.000
A41.2 Septicaemia due to unspecified staphylococcus	0.003	0.997	0.000
T39.1 4-Aminophenol derivatives	0.003	0.997	0.000
D00 Carcinoma in situ of oral cavity, oesophagus and stomach	0.002	0.997	0.000
I08 Multiple valve diseases	0.002	0.998	0.000
I08.8 Other multiple valve diseases	0.002	0.998	0.000
X63.9 Unspecified place	0.002	0.998	0.000
X63.8 Other specified place	0.002	0.998	0.000
X63.7 Farm	0.002	0.998	0.000
X63.6 Industrial and construction area	0.002	0.998	0.000
X63.5 Trade and service area	0.002	0.998	0.000
X63.4 Street and highway	0.002	0.998	0.000
X63.3 Sports and athletics area	0.002	0.998	0.000
X63.2 School, other institution and public administrative area	0.002	0.998	0.000
X63.1 Residential institution	0.002	0.998	0.000
E87 Other disorders of fluid, electrolyte and acid-base balance	0.002	0.998	0.000
C91.1 Chronic lymphocytic leukaemia	0.002	0.998	0.000
G51.0 Bell's palsy	0.002	0.998	0.000
Z37 Outcome of delivery	0.000	0.998	0.002
R82.1 Myoglobinuria	0.000	0.998	0.002
S30.1 Contusion of abdominal wall	0.000	0.998	0.002
I09 Other rheumatic heart diseases	0.002	0.998	0.000
X60-X84 Intentional self-harm	0.002	0.998	0.000
C76.2 Abdomen	0.002	0.998	0.000
Z37.1 Single stillbirth	0.000	0.998	0.002
I08.2 Disorders of both aortic and tricuspid valves	0.002	0.998	0.000
C62.0 Undescended testis	0.000	0.998	0.002
X65 Intentional self-poisoning by and exposure to alcohol	0.002	0.998	0.000
D00.0 Lip, oral cavity and pharynx	0.002	0.998	0.000
G58.9 Mononeuropathy, unspecified	0.002	0.998	0.000
X65.8 Other specified place	0.002	0.998	0.000
G82.1 Spastic paraplegia	0.000	0.998	0.002
J37.0 Chronic laryngitis	0.000	0.998	0.002
W13 Fall from, out of or through building or structure	0.002	0.998	0.000
X60 Intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics	0.002	0.998	0.000
D00.1 Oesophagus	0.002	0.998	0.000
I06.1 Rheumatic aortic insufficiency	0.002	0.998	0.000
C76.8 Overlapping lesion of other and ill-defined sites	0.002	0.998	0.000
C76.7 Other ill-defined sites	0.002	0.998	0.000
C76.5 Lower limb	0.002	0.998	0.000
C76.4 Upper limb	0.002	0.998	0.000
I11 Hypertensive heart disease	0.002	0.998	0.000
C76.1 Thorax	0.002	0.998	0.000
I06.9 Rheumatic aortic valve disease, unspecified	0.002	0.998	0.000
I06.8 Other rheumatic aortic valve diseases	0.002	0.998	0.000
I06.2 Rheumatic aortic stenosis with insufficiency	0.002	0.998	0.000
R82.6 Abnormal urine levels of substances chiefly nonmedicinal as to source	0.000	0.998	0.002
R82.5 Elevated urine levels of drugs, medicaments and biological substances	0.000	0.998	0.002
R82.3 Haemoglobinuria	0.000	0.998	0.002
R82.2 Biliuria	0.000	0.998	0.002
R82.0 Chyluria	0.000	0.998	0.002
D02 Carcinoma in situ of middle ear and respiratory system	0.002	0.998	0.000
X68 Intentional self-poisoning by and exposure to pesticides	0.002	0.998	0.000
I07.9 Tricuspid valve disease, unspecified	0.002	0.998	0.000
I07.8 Other tricuspid valve diseases	0.002	0.998	0.000
I07.2 Tricuspid stenosis with insufficiency	0.002	0.998	0.000
I07.0 Tricuspid stenosis	0.002	0.998	0.000
M85.89 Other specified disorders of bone density and structure (Site unspecified)	0.000	0.998	0.002
Z37.2 Twins, both liveborn	0.000	0.998	0.002
C76.3 Pelvis	0.002	0.998	0.000
I11.0 Hypertensive heart disease with (congestive) heart failure	0.002	0.998	0.000
Z43.5 Attention to cyctostomy	0.002	0.998	0.000
Z95.4 Presence of other heart-valve replacement	0.002	0.998	0.000
S82.30 Fracture of lower end of tibia (closed)	0.002	0.998	0.000
C78.2 Secondary malignant neoplasm of pleura	0.002	0.998	0.000
E87.1 Hypo-osmolality and hyponatraemia	0.002	0.998	0.000
I28 Other diseases of pulmonary vessels	0.002	0.998	0.000
D00.2 Stomach	0.002	0.998	0.000
I08.0 Disorders of both mitral and aortic valves	0.002	0.998	0.000
Z34.0 Supervision of normal first pregnancy	0.000	0.998	0.002
X69 Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances	0.002	0.998	0.000
X67 Intentional self-poisoning by and exposure to other gases and vapours	0.002	0.998	0.000
R82.8 Abnormal findings on cytological and histological examination of urine	0.000	0.998	0.002
W49.9 Unspecified place	0.002	0.998	0.000
I63.3 Cerebral infarction due to thrombosis of cerebral arteries	0.002	0.998	0.000
X63.99 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system; Unspecified place ;During unspecified activity	0.002	0.998	0.000
C76.0 Head, face and neck	0.002	0.998	0.000
E87.4 Mixed disorder of acid-base balance	0.002	0.998	0.000
I06.0 Rheumatic aortic stenosis	0.002	0.998	0.000
M50.3 Other cervical disk degeneration	0.002	0.998	0.000
X68.9 Unspecified place	0.002	0.998	0.000
D01 Carcinoma in situ of other and unspecified digestive organs	0.002	0.998	0.000
Z37.9 Outcome of delivery unspecified	0.000	0.998	0.002
Z37.7 Other multiple births, all stillborn	0.000	0.998	0.002
Z37.6 Other multiple births, some liveborn	0.000	0.998	0.002
Z37.4 Twins, both stillborn	0.000	0.998	0.002
M50 Cervical disk disorders	0.002	0.998	0.000
M71 Other bursopathies	0.002	0.998	0.000
X83 Intentional self-harm by other specified means	0.002	0.998	0.000
D02.2 Bronchus and lung	0.002	0.998	0.000
I09.8 Other specified rheumatic heart diseases	0.002	0.998	0.000
I09.2 Chronic rheumatic pericarditis	0.002	0.998	0.000
I09.1 Rheumatic diseases of endocardium, valve unspecified	0.002	0.998	0.000
I09.0 Rheumatic myocarditis	0.002	0.998	0.000
T83.4 Mechanical complication of other prosthetic devices, implants and grafts in genital tract	0.002	0.998	0.000
X82 Intentional self-harm by crashing of motor vehicle	0.002	0.998	0.000
X81 Intentional self-harm by jumping or lying before moving object	0.002	0.998	0.000
X80 Intentional self-harm by jumping from a high place	0.002	0.998	0.000
X79 Intentional self-harm by blunt object	0.002	0.998	0.000
X77 Intentional self-harm by steam, hot vapours and hot objects	0.002	0.998	0.000
X76 Intentional self-harm by smoke, fire and flames	0.002	0.998	0.000
X75 Intentional self-harm by explosive material	0.002	0.998	0.000
X74 Intentional self-harm by other and unspecified firearm discharge	0.002	0.998	0.000
X73 Intentional self-harm by rifle, shotgun and larger firearm discharge	0.002	0.998	0.000
X72 Intentional self-harm by handgun discharge	0.002	0.998	0.000
X71 Intentional self-harm by drowning and submersion	0.002	0.998	0.000
X70 Intentional self-harm by hanging, strangulation and suffocation	0.002	0.998	0.000
X66 Intentional self-poisoning by and exposure to organic solvents and halogenated hydrocarbons and their vapours	0.002	0.998	0.000
X64 Intentional self-poisoning by and exposure to other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
X60.5 Trade and service area	0.002	0.998	0.000
Y60 Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care	0.002	0.998	0.000
I07.1 Tricuspid insufficiency	0.002	0.998	0.000
X60.1 Residential institution	0.002	0.998	0.000
X69.0 Home	0.002	0.998	0.000
S27.20 Traumatic haemopneumothorax (without open wound into thoracic cavity)	0.000	0.998	0.002
X41.2 School, other institution and public administrative area	0.002	0.998	0.000
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.002	0.998	0.000
X41 Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
X65.9 Unspecified place	0.002	0.998	0.000
X65.0 Home	0.002	0.998	0.000
X65.7 Farm	0.002	0.998	0.000
X65.6 Industrial and construction area	0.002	0.998	0.000
X65.5 Trade and service area	0.002	0.998	0.000
X65.4 Street and highway	0.002	0.998	0.000
X65.3 Sports and athletics area	0.002	0.998	0.000
X65.2 School, other institution and public administrative area	0.002	0.998	0.000
X65.1 Residential institution	0.002	0.998	0.000
Z31.0 Tuboplasty or vasoplasty after previous sterilisation	0.002	0.998	0.000
X61 Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
T84.5 Infection and inflammatory reaction due to internal joint prosthesis	0.000	0.998	0.002
X60.8 Other specified place	0.002	0.998	0.000
X60.2 School, other institution and public administrative area	0.002	0.998	0.000
X78 Intentional self-harm by sharp object	0.002	0.998	0.000
D23.7 Skin of lower limb, including hip	0.002	0.998	0.000
W13.4 Street and highway	0.002	0.998	0.000
X67.9 Unspecified place	0.002	0.998	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.002	0.998	0.000
W13.8 Other specified place	0.002	0.998	0.000
W13.0 Home	0.002	0.998	0.000
W13.7 Farm	0.002	0.998	0.000
W13.6 Industrial and construction area	0.002	0.998	0.000
W13.5 Trade and service area	0.002	0.998	0.000
W13.3 Sports and athletics area	0.002	0.998	0.000
W13.2 School, other institution and public administrative area	0.002	0.998	0.000
W13.1 Residential institution	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations